A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
Not yet recruiting · NCT06672393 · Registry updated 2024-11-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis | Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorder | Not yet recruiting | Phase 3 | 2024-11-04 | NCT06672393 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hansoh BioMedical R&D Company | 37 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huashan Hospital Affiliated to Fudan University | Shanghai | China | 8 |